Webinar: FDA draft guidance for compounding under Section 503(A)
Published date: October 25, 2021
FDA draft guidance for compounding under Section 503(A)
Compounding and compliance experts Greg Burger, Seth DePasquale, Lilit Smith and Mike Jensen share their unique perspectives on the most recent draft and how it will impact compounding for hospitals and health systems.
Visante encourages all hospital and health system compounding teams and pharmacy leads to review and familiarize themselves with this new draft guidance. Specifically, note the change in the 1-mile rule and a new 24-hour use period.
Please access recording here
Please access slides here
Please access Q&A here